Log in

NASDAQ:SGMOSangamo Therapeutics SEC Filings & 10K Form

$11.44
+0.51 (+4.67 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$10.68
Now: $11.44
$11.45
50-Day Range
$6.77
MA: $8.76
$11.51
52-Week Range
$4.81
Now: $11.44
$13.33
Volume2.90 million shs
Average Volume2.26 million shs
Market Capitalization$1.61 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.16

SEC Filings

Sangamo Therapeutics (NASDAQ:SGMO) SEC Filings

DateFilerForm TypeView
05/22/2020
3:46 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2020
4:22 PM
Sangamo Therapeutics (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
4:21 PM
Sangamo Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
4:19 PM
Ramasastry Saira (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
4:18 PM
PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
4:17 PM
Meyers James R (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
4:14 PM
DILLY STEPHEN GEORGE (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
4:13 PM
Carey Robert (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:08 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
5:05 PM
McClung David Mark (Reporting)
Sangamo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/28/2020
5:59 PM
Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2020
3:50 PM
BIOGEN INC. (Reporting)
Biogen MA Inc. (Reporting)
Sangamo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2020
3:13 PM
BIOGEN INC. (Filed by)
Sangamo Therapeutics (Subject)
Form SC 13G
03/26/2020
6:18 PM
Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
4:18 PM
Sangamo Therapeutics (Filer)
Form PRE 14A
03/19/2020
6:55 PM
PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
8:09 PM
DILLY STEPHEN GEORGE (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2020
4:41 PM
Sangamo Therapeutics (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
3:53 PM
Sangamo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2020
6:16 AM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2020
10:54 AM
LOEB GARY (Reporting)
Sangamo Therapeutics (Issuer)
Form 4/A
02/27/2020
9:40 AM
Sangamo Therapeutics (Issuer)
Woolfson Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
6:50 PM
Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
Form 4/A
02/26/2020
6:34 PM
Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
6:33 PM
Ramelmeier Rolf Andrew (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
6:32 PM
LOEB GARY (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
6:31 PM
Lee Sung (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
6:31 PM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
6:29 PM
Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
7:15 PM
Markels John (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
7:04 PM
Markels John (Reporting)
Sangamo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2020
2:24 PM
Sangamo Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
02/12/2020
5:33 PM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/12/2020
10:01 AM
Sangamo Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/03/2020
4:52 PM
LOEB GARY (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
8:16 AM
Sangamo Therapeutics (Filer)
Form CT ORDER
01/28/2020
6:11 PM
Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
7:03 AM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
3:54 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:33 PM
Sangamo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:25 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
4:27 PM
Lee Sung (Reporting)
Sangamo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/04/2019
3:16 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
5:15 PM
Ramelmeier Rolf Andrew (Reporting)
Sangamo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2019
4:10 PM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:44 PM
Sangamo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:37 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
4:02 PM
Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2019
3:02 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
4:13 PM
Sangamo Therapeutics (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
4:09 PM
Sangamo Therapeutics (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
4:08 PM
Ramasastry Saira (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
4:07 PM
PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
4:06 PM
DILLY STEPHEN GEORGE (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
4:04 PM
Carey Robert (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:41 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
7:02 AM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:34 PM
Sangamo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
3:32 PM
Sangamo Therapeutics (Filer)
Form DEFA14A
04/25/2019
3:31 PM
Sangamo Therapeutics (Filer)
Form DEF 14A
04/18/2019
5:47 PM
Sangamo Therapeutics (Issuer)
Woolfson Adrian (Reporting)
Form 3/A
04/17/2019
3:45 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
6:27 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2019
4:03 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
4:02 PM
Sangamo Therapeutics (Filer)
Form 424B5
04/03/2019
3:08 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2019
4:09 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
6:35 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:21 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
3:15 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
7:20 PM
Sangamo Therapeutics (Issuer)
Woolfson Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:20 PM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:19 PM
Sangamo Therapeutics (Issuer)
Turner Heather D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:18 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:17 PM
Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
2:29 PM
Sangamo Therapeutics (Filer)
Form CT ORDER
02/26/2019
2:22 PM
Sangamo Therapeutics (Filer)
Form CT ORDER
02/13/2019
8:47 AM
Sangamo Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/13/2019
5:08 AM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2019
4:27 PM
BlackRock Inc. (Filed by)
Sangamo Therapeutics (Subject)
Form SC 13G/A
01/28/2019
4:46 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
4:45 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
4:45 PM
Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
6:06 PM
Sangamo Therapeutics (Issuer)
Woolfson Adrian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2019
3:08 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
4:38 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
4:35 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2018
6:46 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
11:06 AM
Sangamo Therapeutics (Filer)
Form CT ORDER
11/26/2018
8:11 PM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
4:16 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2018
6:08 PM
PARKER H STEWART (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
4:09 PM
Sangamo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:33 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
4:41 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
3:25 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
6:25 PM
Sangamo Therapeutics (Issuer)
Yi Kathy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2018
4:40 PM
Conner Edward R. (Reporting)
Sangamo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2018
11:01 AM
Boissel Stephane (Reporting)
Sangamo Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2018
3:15 PM
Sangamo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.